Panacea Biotec share news, announcements and annual reports
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Panacea Biotec Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹329.05up ₹9.80 (3.07%)BSE ₹328.10
Share price at the NSE close on 28 Oct 2026. Previous close ₹319.25.
28 Oct: open ₹319.05, high ₹333.55, low ₹317.50
52-week range of traded prices to 28 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,015 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 56,92237.5% delivered
Panacea Biotec shareholder meetings
106 filed, newest first. Page 3 of 3.
Aug 2008
20 Aug · Meeting
Panacea Biotec Ltd. has informed the Exchange that as per Section 192A of the Companies Act, 1956 read with Companies (Passing of Resolution by Postal Ballot) Rules, 2001, proposal for creation of mortgage/charge and/or hypothecation from time to time on all the immovable and movable properties present & future of the Company under section 293(1)(a) of the Companies Act, 1956 has to be approved by the shareholders of the Company by way of a postal Ballot. Similarly the approval of shareholders under section 293(1)(d) of the Act for increase in the borrowing powers of the Board of Directors of the Company can be obtained by way of postal Ballot. The Company has appointed Mr. U.K. Singhal of M/s. Singhal Law Associates, Advocates, as Scrutinizer to scrutinize the Postal Ballot in a fair and transparent manner. The duly completed postal ballot form should reach the scrutinizer before the close of working hours, on or before September 13, 2008. The Scrutinizer will submit his report to the chairman and the result of the postal ballot will be announced by the Chairman at the Annual General Meeting scheduled to be held on September 27, 2008. A copy of the notice of Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
29 Jul · Meeting
Panacea Biotec Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on July 28, 2008 has decided as under: (1) The Annual General Meeting of the Company has been convened to be held on September 27, 2008. (2) The Register of members and Share Transfer Books will remain closed from September 23, 2008 to September 27, 2008 (both days inclusive) for the purpose of Annual General Meeting and ascertaining the list of members entitled to receive the dividend on Equity Shares, if any, declared at the said meeting.
Jun 2008
16 Jun · Meeting
Panacea Biotec Ltd. has informed the Exchange that as per Section 192A of the Companies Act, 1956 read with Companies (Passing of Resolution by Postal Ballot) Rules, 2001, proposal for alteration in Objects Clause of Memorandum of Association has to be approved by the shareholders of the Company by way of a Postal Ballot. Similarly the approval of shareholders under Section 149(2A) of the Act for commencement of any object(s) covered under Other Objects clause of the Memorandum of Association can be obtained by way of Postal Ballot. Accordingly, the shareholders consent for following resolutions is being seek through Postal Ballot: (1) Special Resolution under Section 17 of the Companies Act, 1956 for alteration in Objects Clause by way of inserting new sub-clause 39, 40 & 41 after the existing sub-clause 38 of Clause III-C ( Other Objects ). (2) Special Resolution under Section 149(2A) of the Act for approval for commencement of Objects mentioned under new sub-clauses 39, 40 & 41 of Clause III-C (Other Objects).The duly completed postal ballot form should reach the scrutinizer before the close of working hours, on or before July 02, 2008. The Company has appointed Mr. Sandeep Agarwal of M/s. U.S. & Associates, Company Secretaries, as Scrutinizer to scrutinize the Postal Ballot in a fair and transparent manner. The Scrutinizer will submit his report to the chairman and the result of the postal ballot will be announced by the Chairman on July 14, 2008. A copy of the notice of Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
9 Oct · Meeting
Panacea Biotec Ltd. has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on September 29, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
25 Jul · Meeting
Panacea Biotec Ltd. has informed the Exchange that the Company's Register of Members and Share Transfer Books shall remain closed from September 25, 2007 to September 29, 2007 (both days inclusive) for ascertaining the entitlement to receive dividend, if any, declared by the Shareholders in the ensuing Annual General Meeting scheduled to be held on September 29, 2007.
Jan 2007
9 Jan · Meeting
Panacea Biotec Ltd. has informed the Exchange that pursuant to Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution by Postal Ballot) Rules, 2001 that the following resolutions are proposed to be passed by the shareholders of the Company by way of a Postal Ballot: 1) Ordinary Resolution under Section 293(1)(a) of the Companies Act, 1956 authorising the Board of Directors to mortgage and/or charge any of its movable and/or immovable properties or the whole or substantially the whole of an undertaking or undertakings of the Company. 2) Special Resolution for Alteration in the Articles of Association by way of substitution of Article 2. 3) Special Resolution for Alteration in the Articles of Association by way of substitution of Article 143. The duly completed postal ballot form should reach the scrutinizer before the close of working hours, on or before February 09, 2007. The Company has appointed Mr. Umesh Singhal of M/s. U.S. & Associates, Company Secretaries, as Scrutinizer to scrutinize the Postal Ballot in a fair and transparent manner. The result of the postal ballot will be announced by the Chairman on February 16, 2007. A copy of the Postal Ballot Notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.